The Global Progressive Pulmonary Fibrosis Treatment Industry is on track for steady expansion, driven by increasing demand for effective treatment solutions. According to Future Market Insights (FMI), the market is expected to reach a valuation of US$3.72 million by 2033. This growth trajectory reflects a promising Compound Annual Growth Rate (CAGR) of 7.5% anticipated from …